Matthew Pakizegee, PharmD, MS

Clinical Pathways GPS

Engaging Patients in Care Through Greater Access to Medical Records and Clinical Pathways

04/16/2019

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Without interoperability of medical records between health systems, patients are the best chance for the medical system to provide continuity of care when medical records from a different health system are difficult...

...

04/16/2019

Journal of Clinical Pathways

Clinical Pathways GPS

CMS Policies Concerning CAR T-Cell Therapy

05/15/2019

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Matthew Pakizegee , PharmD, MS;

Chimeric antigen receptor (CAR) T-cell therapy is a new form of cancer therapy that uses a patient’s own immune system to fight the disease. This type of cell therapy uses an individualized process to develop a...

...

05/15/2019

Journal of Clinical Pathways